Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
256.8 USD | +1.61% | -2.28% | +11.01% |
May. 29 | Agilent lowers full-year revenue forecast on slowing demand from its biotech clients | RE |
May. 23 | Some of the biggest splits in Corporate America | RE |
Evolution of the average Target Price on Danaher Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Danaher Corporation
Raymond James | |
HSBC | |
TD Cowen | |
Barclays | |
Citigroup | |
Baird | |
Leerink Partners | |
RBC Capital Markets | |
Goldman Sachs | |
Evercore ISI | |
KeyBanc Capital Markets | |
UBS | |
Deutsche Bank Securities | |
BofA Securities | |
Morningstar | |
Wells Fargo Securities | |
Jefferies & Co. | |
SVB Securities LLC | |
Nephron Research | |
JPMorgan Chase | |
Stifel Nicolaus | |
Credit Suisse | |
Cowen | |
Benchmark Company | |
Bernstein | |
B. Riley | |
Benchmark Capital |
EPS Revisions
- Stock Market
- Equities
- DHR Stock
- Consensus Danaher Corporation